GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » Equity-to-Asset

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Equity-to-Asset : 0.54 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Garden Biopharmaceutical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Zhejiang Garden Biopharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥3,005 Mil. Zhejiang Garden Biopharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥5,521 Mil. Therefore, Zhejiang Garden Biopharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.54.

The historical rank and industry rank for Zhejiang Garden Biopharmaceutical Co's Equity-to-Asset or its related term are showing as below:

SZSE:300401' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52   Med: 0.88   Max: 0.96
Current: 0.54

During the past 13 years, the highest Equity to Asset Ratio of Zhejiang Garden Biopharmaceutical Co was 0.96. The lowest was 0.52. And the median was 0.88.

SZSE:300401's Equity-to-Asset is ranked worse than
54.28% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs SZSE:300401: 0.54

Zhejiang Garden Biopharmaceutical Co Equity-to-Asset Historical Data

The historical data trend for Zhejiang Garden Biopharmaceutical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Garden Biopharmaceutical Co Equity-to-Asset Chart

Zhejiang Garden Biopharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.81 0.65 0.62 0.55

Zhejiang Garden Biopharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.52 0.54 0.55 0.54

Competitive Comparison of Zhejiang Garden Biopharmaceutical Co's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Garden Biopharmaceutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Garden Biopharmaceutical Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Garden Biopharmaceutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Zhejiang Garden Biopharmaceutical Co's Equity-to-Asset falls into.



Zhejiang Garden Biopharmaceutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Zhejiang Garden Biopharmaceutical Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2893.13/5260.592
=0.55

Zhejiang Garden Biopharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=3005.406/5520.999
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Garden Biopharmaceutical Co  (SZSE:300401) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Zhejiang Garden Biopharmaceutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Zhejiang Garden Biopharmaceutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Business Description

Traded in Other Exchanges
N/A
Address
No. 166, Street 20, Economic & Technological Development Zone, Zhejiang, Hangzhou, CHN, 310018
Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.
Executives
Shao Xu Jun Director
Liu Xiao Ping Executives
Shao Qin Xiang Director
Shao Jun Fang Director
Liu Jian Gang Directors, executives
Qian Guo Ping Executives
Zhu Jian Xing Supervisors
Yu Quan Heng Directors, executives, directors
Ma Huan Zheng Directors, executives
Li Hui Ying Supervisors
Ma Wen De Director
Chen Yi Executives
Gu Yi Kang Independent director

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Headlines

No Headlines